Pancreatitis Trial, Recruiting NCT07174609 Sponsor: Johns Hopkins University Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT07174609
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with chronic pancreatitis and have ongoing abdominal pain that has not been relieved by standard treatments
  • You are able to read and sign a consent form written in English
  • You have a good enough understanding of English to fill out questionnaires as part of the study
  • You have reliable and regular access to a phone, as you will need to be contacted for follow-up

Who may not be able to join:

  • You are not willing or not able to sign a written consent form
  • You have a serious medical or mental health condition that could interfere with taking part in the study (confirm with trial site)
  • You are currently pregnant or breastfeeding
  • You have a coronary stent, pacemaker, defibrillator, aneurysm clips, or any other implanted metal or electrical device in your body
  • You have a history of epilepsy, a traumatic brain injury, or a heart attack in the last 6 months
  • You have a skin condition, such as open wounds, in areas where electrodes (small sensor pads) would need to be placed on your skin
  • You have any other condition that the study doctor feels could put you at risk or stop you from fully taking part in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mahya Faghih, Johns Hopkins University

Phone: 443-287-4680

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility as assessed by enrollment rate; Feasibility as assessed by treatment adherence; Feasibility as assessed by treatment adherence rate; Feasibility as assessed by retention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov